Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
It was simply the pre-clinal data published before applying for the SA clinical trial
Article printed 18th June 2021.
The RNS announcing the application for the SA trial also has a link to this article
https://www.lse.co.uk/rns/SCLP/covidity-trial-planned-in-south-africa-and-uk-c1mxawt3owjx27b.html
"The preclinical data and paper titled "A novel bivalent DNA vaccine encoding both spike protein receptor-binding domain and nucleocapsid protein of SARS-CoV-2 to elicit T cell and neutralising antibody responses that cross react with variants" can be viewed via BioRxiv with the following link: https://www.biorxiv.org/content/10.1101/2021.06.18.448932v1."
But I believe that this article was first published back in 2021
https://europepmc.org/article/PPR/PPR359069
So its a confirmed fact that the original announcement was in working days?
"Lots of buys in the morning and nothing in the afternoon.
What does this mean?"
An alternative explanation
The buyer starts drinking on market open, steadily gets more p***ed and the buys get bigger as all sense is lost.
By afternoon the buyer is comatose. 🤣
FOMO not for me
I'm more in the GINITS camp🤣
Cleaner
I suspect Texas Biomed belatedly decided that Scancell is a company that is worth being associated with.
Perhaps they did a little research into Immunobody and the previous SCIB1 trial, and this was the catalyst for the announcement. Who knows?
But there is certainly no evidence of any ongoing collaboration with Scancell, and if such a collaboration existed it would surely have been RNS'd.
My take on this is that Texas Biomed helped in the testing of the early versions of the Covidity vaccines since they have bio secure facilities. End of story.
I wonder if Turner Pope know about the Crackin inverse indicator
That's a really interesting article from Turner Pope. The support level that the Aim index is looking to rebound from looks very compelling as do the arguments supporting such a rebound.
"TF, you can't argue that prior to the last RNS we rose strongly whether the info came from Scancell or not ."
I cannot see senior Scancell staff trading on the basis of the Scope trial continuing to produce excellent results.
However, the good news will inevitably spread from all connected to the Scope trial. This includes patients and their friends and relatives, hospital staff and anyone else connected to the trial. News spreads fast especially with the help of social media.
Shucks, so when he said "the best is yet to come", he was talking about tomato seeds 😂
There's a lot of knowledge on this BB with no evidence to back it up
Porky, I'm certainly impressed that it only took you one minute to type your last post 😂
What I am getting is how accurate are the tumour measurements and how open are they to mis-interpretation?
I think we have had a similar discussion in the past on this BB.
Thanks for highlighting these discrepancies Burble.
Tell me, is this likely to be discrepancies in the Scancell reporting?
Alternatively small changes in estimating the tumour reductions by the clinicians when reporting the data to Scancell?
BOJO
Also on the poster:
"As of early October 2023:
• 17 pts in whom the combinations of ipilimumab
with nivolumab was planned (cohort 1), were
vaccinated with 8mg SCIB1 i.m. using a needle
free injections system (Pharmajet)."
So, it would appear that recruitment is going well, so more data is being accumulated fairly quickly.
We've not heard the word "Trailblazing" before from Scancell.
Could this indicate that the continuing data (i.e. post the last RNS on the Scope trial) is adding to the already great results?
GF
"Quick question. If we know “90% chance of a positive outcome on the current SCIB1 trial” why haven’t Trinity adjusted their valuation? "
Yes, I assume Scancell have proved that from a sample of 11 with 9 responders, that a statistical analysis proves there is a 90% chance of the trial hitting its stated endpoint (was it 70% responders, I can't remember).
It does look like they have not taken this into account in their own calculations.
Nobody really knows what is going on so people are just supporting their own particular agenda ad nauseam.
ChatGBT and the like is clever IT but not intelligent